Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Journal of Bone Oncology
|
February 25, 2016
Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL
Gaëlle Picarda, Etienne Matous, Jérôme Amiaud, et al.
International Journal of Cancer
|
June 26, 2014
BYL719, a new α-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma
Bérengère Gobin, Marc Baud' Huin, François Lamoureux, et al.
American Journal of Cancer Research
|
December 9, 2017
Bone microenvironment has an influence on the histological response of osteosarcoma to chemotherapy: retrospective analysis and preclinical modeling
Vincent Crenn, Kevin Biteau, Jérôme Amiaud, et al.
Frontiers in Oncology
|
November 12, 2021
Involvement of the TGF-β Signaling Pathway in the Development of YAP-Driven Osteosarcoma Lung Metastasis
Sarah Morice, Geoffroy Danieau, Robel Tesfaye, et al.
Sarcoma
|
February 19, 2011
A"Proteoglycan targeting strategy" for the scintigraphic imaging and monitoring of the swarm rat chondrosarcoma orthotopic model
Caroline Peyrode, François Gouin, Aurélien Vidal, et al.
European Journal of Cell Biology
|
October 26, 2010
Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: role in osteoclastogenesis and bone resorption
Marc Baud'huin, Carmen Ruiz-Velasco, Gaëtan Jego, et al.
Cancer Research
|
September 16, 2010
Zoledronic acid as a new adjuvant therapeutic strategy for Ewing's sarcoma patients
Guillaume A Odri, Sophie Dumoucel, Gaëlle Picarda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2014
Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma
Audrey Lamora, Julie Talbot, Gwenola Bougras, et al.
American Journal of Cancer Research
|
May 9, 2022
Signature of the vascular tumor microenvironment as a marker of the therapeutic response to doxorubicin in a preclinical model of osteosarcoma
Vincent Crenn, Jérôme Amiaud, Anne Gomez-Brouchet, et al.
Bioconjugate Chemistry
|
May 3, 2019
12b80 - Hydroxybisphosphonate Linked Doxorubicin: Bone Targeted Strategy for Treatment of Osteosarcoma
Emmanuelle David, Sébastien Cagnol, Jean-Yves Goujon, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Journal of Bone Oncology
|
February 25, 2016
Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL
Gaëlle Picarda, Etienne Matous, Jérôme Amiaud, et al.
International Journal of Cancer
|
June 26, 2014
BYL719, a new α-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma
Bérengère Gobin, Marc Baud' Huin, François Lamoureux, et al.
American Journal of Cancer Research
|
December 9, 2017
Bone microenvironment has an influence on the histological response of osteosarcoma to chemotherapy: retrospective analysis and preclinical modeling
Vincent Crenn, Kevin Biteau, Jérôme Amiaud, et al.
Frontiers in Oncology
|
November 12, 2021
Involvement of the TGF-β Signaling Pathway in the Development of YAP-Driven Osteosarcoma Lung Metastasis
Sarah Morice, Geoffroy Danieau, Robel Tesfaye, et al.
Sarcoma
|
February 19, 2011
A"Proteoglycan targeting strategy" for the scintigraphic imaging and monitoring of the swarm rat chondrosarcoma orthotopic model
Caroline Peyrode, François Gouin, Aurélien Vidal, et al.
European Journal of Cell Biology
|
October 26, 2010
Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: role in osteoclastogenesis and bone resorption
Marc Baud'huin, Carmen Ruiz-Velasco, Gaëtan Jego, et al.
Cancer Research
|
September 16, 2010
Zoledronic acid as a new adjuvant therapeutic strategy for Ewing's sarcoma patients
Guillaume A Odri, Sophie Dumoucel, Gaëlle Picarda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2014
Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma
Audrey Lamora, Julie Talbot, Gwenola Bougras, et al.
American Journal of Cancer Research
|
May 9, 2022
Signature of the vascular tumor microenvironment as a marker of the therapeutic response to doxorubicin in a preclinical model of osteosarcoma
Vincent Crenn, Jérôme Amiaud, Anne Gomez-Brouchet, et al.
Bioconjugate Chemistry
|
May 3, 2019
12b80 - Hydroxybisphosphonate Linked Doxorubicin: Bone Targeted Strategy for Treatment of Osteosarcoma
Emmanuelle David, Sébastien Cagnol, Jean-Yves Goujon, et al.
Page
of 5